| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Academic Elite and Arrogance at Parties |
|
Advice You - Academic Elite and Arrogance at Parties
Many people get offended by PhD type people who will not give them the time of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product day at parties. Often people feel slighted, as they simply brush them off and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in refuse to chit chat. Not long ago someone mentioned this and indeed we have a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. l probably witnessed this behavior at one time or another, so it was decent co here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe mmentary and a worthy subject. Thus, I felt obligated to take the PhD person' d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s point of view and attempted to debate their possible thoughts. So, I said; o ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc course there is a flip side to all this. That is that if those who are propel easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ling BS are allowed to continue, then the person listening is soaking it in. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically For instance - Talking about the weather is fine, for a few minutes and all th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ how do you do stuff as well. Yet, when the BS starts flying and these are thi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ngs you have heard over and over again and again, sometimes it is insincere to ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a continue to listen and "pretend" that you are buying into it all. If the BS' dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r demands to be listened too and calls a foul if they are graciously exited th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin en it is the person who demands who would be the lesser right? So, in this cas tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e if the BS'er called the non-listener arrogant as they felt slighted or perha t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s disrespected, then their comments are merely "revengeful" in nature and shou ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ld also be taken with a grain of salt. So this is the flip side of the argume y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nt as I understand it and recently, I had this conversation with someone in ou . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de think tank about this very subject and thus I am so glad to have you address elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip this issue. I suppose therefore there are two sides to every human interaction tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How Do You Keep Your Business Name In Front Of Your Customer? Online Resume Not Generating any Calls? Blame Culture Blues - How the Language of Blame Manifests Organisational Underperformance
|